Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pact
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
- Latest
- Trending
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
The French government has halted its electric car subsidy program due to overwhelming demand. The initiative aimed to make electric ...
AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Gas fees on the Ethereum network have soared to a multi-month high due to increased transaction volume, causing concern among ...
Hasbro is set to release its Q4 results, with a predicted profit increase but a 20% decline in revenue. Analysts ...
Loop Capital upgrades Corteva Inc. rating to Buy and raises price target to $65. Corteva's strong earnings guidance and potential ...
Online retail platform Temu poses a competitive threat to Amazon with its aggressive marketing approach, highlighted by heavy investment in ...
Pegasystems is expected to announce strong fourth-quarter results, supported by stable spending and ongoing digital transformation initiatives. Analysts believe in ...
The S&P 500 reaches a record high despite challenges and reduced rate cut expectations. Solid earnings and stable oil prices ...
Take-Two Interactive's price target is adjusted to $180 by Wolfe Research, citing strong performance and potential for earnings growth.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.